PLOS MED: Telmisartan can reduce the risk of stroke and dementia in patients with diabetes + hypertension
Ann Intern Med: Three-year results of bariatric surgery for patients with obesity and hypertension
"Hypertension" Which antihypertensive drug is safer?
JAMA Neurology-incidental intracranial hypertension, or lumbar puncture is not recommended
Renfu Medicine: Metoprolol Succinate Sustained-Release Tablets Obtained US FDA Approval Number
Zhongchao Medical and GlaxoSmithKline renews contract to continue cooperation in the field of pulmonary hypertension
Development of an efficient preparation process for the key intermediate of the hypertension drug Telmisartan
Heart and God masters talk about the breakthrough in the treatment of stroke combined with hypertension!
Hypertension: The trajectory of serum uric acid changes in youth and cardiovascular events in middle-aged
The results of the selection of 5 kinds of hypertension drugs in the collection of indapamide, felodipine...
Liver cirrhosis and portal hypertension bleeding-when is transjugular intrahepatic portosystemic shunt (TIPS)?
The largest study to date has shown that the relationship between hypertension and dementia is regulated by Tau protein. Clinical discoveries
Cell Sub-Journal: Scientists Reveal a New Type of Hypertensive Neurons
Shacubatril and Valsartan is officially approved for hypertension indication!
Xinlitai hypertension drug allisartan medoxomil and indapamide sustained-release tablets received clinical approval
ARNI optimizes the management of stroke and hypertension, and overcomes the barrier-free blood pressure at night!
J INTERN MED: Pulmonary hypertension is associated with increased incidence of NAFLD
New drug for treatment of essential hypertension approved in China to lower blood pressure while reducing the risk of cardiovascular events
disorders, hypertension and cardiovascular disease and the diagnosis and treatment process
The State Food and Drug Administration approves the world's first ARNI hypertension indication